IMN: The Institutional Capital & Cannabis Conference (East)
- Bodamer, Benton B. Waite, Melissa L. .
- Conferences
-
Convene, 117 West 46th Street, New York City, New York, 10036
Want to get our alerts?
Click “Subscribe Now” to get attorney insights on the latest developments in a range of services and industries.
Join Benton Bodamer and Melissa Waite at the Information Management Network (IMN) IC3: The Institutional Capital & Cannabis Conference (East) on October 21, 2019 at the Convene in New York City. Dickinson Wright is proud to be a Patron Sponsor of this event.
The 7th Annual Institutional Capital & Cannabis Conference (IC3) is the leading investor forum for the legal cannabis industry. IC3 brings together investors who wish to invest or learn more about this high-growth new asset class, cannabis companies and investment funds who are looking to raise money or showcase their products, and professional service providers who facilitate these groups doing business.
Benton Bodamer (Member, Columbus) will discuss federal legalization and the pathway to the end of prohibition during the “Crystal Balling the Future of Cannabis” panel, while Melissa Waite (Member, Las Vegas) will discuss the opportunities and challenges associated with owning real estate used in the cannabis supply chain during the “Investment Strategies Involving Cannabis Real Estate” panel.
For more information on the IC3 Conference, please see below:
IC3 East Conference
Date: October 21, 2019
Time: 8:00 am – 6:00 pm
Location: Convene, 117 West 46th Street, New York City, NY 10036
To learn more about the IC3 Conference or to register, please click here.
The 7th Annual Institutional Capital & Cannabis Conference (IC3) is the leading investor forum for the legal cannabis industry. IC3 brings together investors who wish to invest or learn more about this high-growth new asset class, cannabis companies and investment funds who are looking to raise money or showcase their products, and professional service providers who facilitate these groups doing business.
Benton Bodamer (Member, Columbus) will discuss federal legalization and the pathway to the end of prohibition during the “Crystal Balling the Future of Cannabis” panel, while Melissa Waite (Member, Las Vegas) will discuss the opportunities and challenges associated with owning real estate used in the cannabis supply chain during the “Investment Strategies Involving Cannabis Real Estate” panel.
For more information on the IC3 Conference, please see below:
IC3 East Conference
Date: October 21, 2019
Time: 8:00 am – 6:00 pm
Location: Convene, 117 West 46th Street, New York City, NY 10036
To learn more about the IC3 Conference or to register, please click here.
Related Practices
Contacts
Recent Insights
- Conferences MJBizDaily Investor Intelligence Conference
- Speaking Engagements William Honaker Authors “A Business Owner’s Guide to Intellectual Property: Turn Your Ideas Into Gold”
- Webinars Global Chamber USMCA/NAFTA Update: Shifting Issues & Challenges Webinar
- September 12, 2024 Media Mentions Lloyd Pierre-Louis was recently quoted in the Spectrum News 1 article, “The laws and regulations around Ohio's recreational marijuana,”
- September 5, 2024 In the News Scot Crow Named to the 2024 Top 200 Cannabis Lawyers List
- August 12, 2024 Media Mentions Benjamin Sobczak was recently quoted in Crain’s Detroit Business article, “Medical, recreational marijuana licenses would be merged under lawmakers’ proposal."
- July 09, 2024 Media Mentions Jonathan Wachs was recently quoted in the Law360 article, “Dickinson Wright Adds Longtime Offit Kurman Principal in DC."
- June 21, 2024 Media Mentions Jonathan Wachs was quoted this week in the Baltimore Business Journal article “Maryland to Award 31 More Cannabis Business Licenses.”
- June 20, 2024 In the News Benton Bodamer, Taylor MacDonald, and Benjamin Sobczak recently authored “Cliffs Without Fences and Fences Without Cliffs: Exploring the Emerging Conflicts Between Quasi-Legal Intoxicating Hemp and Regulated State-Legal Cannabis” for the Ohio State Legal Studies Research Paper, No. 855, Drug Enforcement and Policy Center.